Abstract
During the next years, molecular diagnostic science and the pharmaceutical industry will face increasing demand for personalized medicine. Therapeutic treatments should be tailored to the needs of individual patient. Patients will inquire for information about potential tumor detection at an early stage when disease can be more likely to be arrested or cured with specific regimens of drug therapy. To respond to this demand, science and industry need to modulate therapeutic approaches to the continuous development of cancer. Now more than ever, it is necessary to fill the knowledge hiatus between the "beginning" and the "end" of cancer development, i.e we need to critically analyze the extensive multistep process of cancer development that still remains poorly understood.
| Original language | English |
|---|---|
| Pages (from-to) | 108-114 |
| Number of pages | 7 |
| Journal | Journal of Experimental Therapeutics and Oncology |
| Volume | 3 |
| Issue number | 3 |
| DOIs | |
| State | Published - May 2003 |
Keywords
- Epigenetic agents
- Modulation of carcinogen activity
- Molecular epidemiology
- The reductionist approach
Fingerprint
Dive into the research topics of 'Cancer prevention and therapy: Strategies and problems'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver